161 related articles for article (PubMed ID: 38299750)
1. Screening candidate diagnostic biomarkers for diabetic kidney disease.
Huang X; Zhang H; Liu J; Yang X; Liu Z
J Clin Lab Anal; 2024 Feb; 38(3):e25000. PubMed ID: 38299750
[TBL] [Abstract][Full Text] [Related]
2. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of quantitative contrast-enhanced ultrasound (CEUS) for early detection of renal hyperperfusion in diabetic kidney disease.
Wang L; Wu J; Cheng JF; Liu XY; Ma F; Guo LH; Xu JM; Wu T; Mohan C; Peng A; Xu HX; Song YX
J Nephrol; 2015 Dec; 28(6):669-78. PubMed ID: 25712236
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Non-Invasive Urinary Exosomal Biomarker for Diabetic Nephropathy Using Data-Independent Acquisition Proteomics.
Ding X; Zhang D; Ren Q; Hu Y; Wang J; Hao J; Wang H; Zhao X; Wang X; Song C; Du J; Yang F; Zhu H
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686366
[TBL] [Abstract][Full Text] [Related]
5. Differential Urinary Proteome Analysis for Predicting Prognosis in Type 2 Diabetes Patients with and without Renal Dysfunction.
Ahn HS; Kim JH; Jeong H; Yu J; Yeom J; Song SH; Kim SS; Kim IJ; Kim K
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545899
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of UbA52 level in the urine of patients with type 2 diabetes mellitus and diabetic kidney disease.
Xu X; Dong Y; Liu M; Li Y; Zhang Y
Nefrologia (Engl Ed); 2021; 41(5):548-555. PubMed ID: 36165137
[TBL] [Abstract][Full Text] [Related]
7. A candidate panel of eight urinary proteins shows potential of early diagnosis and risk assessment for diabetic kidney disease in type 1 diabetes.
Altman J; Bai S; Purohit S; White J; Steed D; Liu S; Hopkins D; She JX; Sharma A; Zhi W
J Proteomics; 2024 May; 300():105167. PubMed ID: 38574989
[TBL] [Abstract][Full Text] [Related]
8. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H
Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550
[TBL] [Abstract][Full Text] [Related]
9. Changes in urine proteome accompanying diabetic nephropathy progression.
Lewandowicz A; Bakun M; Kohutnicki R; Fabijańska A; Kistowski M; Imiela J; Dadlez M
Pol Arch Med Wewn; 2015; 125(1-2):27-38. PubMed ID: 25578432
[TBL] [Abstract][Full Text] [Related]
10. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
[TBL] [Abstract][Full Text] [Related]
11. Proteomic profiling and correlations with clinical features reveal biomarkers indicative of diabetic retinopathy with diabetic kidney disease.
Fan X; Xu M; Chen X; Ren Q; Fan Y; Wang R; Chen J; Cui L; Wang Z; Sun X; Guo N
Front Endocrinol (Lausanne); 2022; 13():1001391. PubMed ID: 36277688
[TBL] [Abstract][Full Text] [Related]
12. Serum and Urinary Progranulin in Diabetic Kidney Disease.
Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
[TBL] [Abstract][Full Text] [Related]
13. In-depth urinary and exosome proteome profiling analysis identifies novel biomarkers for diabetic kidney disease.
Du S; Zhai L; Ye S; Wang L; Liu M; Tan M
Sci China Life Sci; 2023 Nov; 66(11):2587-2603. PubMed ID: 37405567
[TBL] [Abstract][Full Text] [Related]
14. Insights into serum metabolic biomarkers for early detection of incident diabetic kidney disease in Chinese patients with type 2 diabetes by random forest.
Jiang JJ; Sham TT; Gu XF; Chan CO; Dong NP; Lim WH; Song GF; Li SM; Mok DK; Ge N
Aging (Albany NY); 2024 Feb; 16(4):3420-3530. PubMed ID: 38349886
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease.
Ren X; Wang W; Cao H; Shao F
Front Endocrinol (Lausanne); 2023; 14():1180338. PubMed ID: 37305031
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy.
Wei J; Wang B; Shen FJ; Zhang TT; Duan Z; Zhou DM
BMC Nephrol; 2022 Jul; 23(1):270. PubMed ID: 35896961
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of urinary autophagy transcripts expression in diabetic kidney disease.
Matboli M; Azazy AEM; Adel S; Bekhet MM; Eissa S
J Diabetes Complications; 2017 Oct; 31(10):1491-1498. PubMed ID: 28760651
[TBL] [Abstract][Full Text] [Related]
18. Circulating Expression Level of LncRNA Malat1 in Diabetic Kidney Disease Patients and Its Clinical Significance.
Zhou LJ; Yang DW; Ou LN; Guo XR; Wu BL
J Diabetes Res; 2020; 2020():4729019. PubMed ID: 32832561
[TBL] [Abstract][Full Text] [Related]
19. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
[TBL] [Abstract][Full Text] [Related]
20. Urinary Post-Translationally Modified Fetuin-A (uPTM-FetA) in Chronic Kidney Disease Patients with and without Diabetic Kidney Disease.
Musolino M; Greco M; D'Agostino M; Tripodi L; Misiti R; Dragone F; Cianfrone P; Zicarelli M; Foti DP; Andreucci M; Bolignano D; Coppolino G
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
